Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
Amy Trentham-DietzMehmet Ali ErgunOguzhan AlagozNatasha K StoutRonald E GangnonJohn M HamptonKim DittusTed A JamesPamela M VacekSally D HerschornElizabeth S BurnsideAnna N A TostesonDonald L WeaverBrian L SpraguePublished in: Breast cancer research and treatment (2017)
A prognostic test that identifies non-progressive DCIS would substantially reduce treatment costs but result in only modest improvements in quality of life when averaged over all DCIS cases.